ADVFN ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Eyenovia Inc

Eyenovia Inc (EYEN)

15.82
0.00
(0.00%)
15.82
0.00
( 0.00% )

Eyenovia Inc (EYEN) 주식 가격

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
15.82
( - )
매수가
15.30
매도가
15.58
거래량
-
0.00 일간 변동폭 0.00
0.85 52주 범위 124.80
market_cap
전일 종가
15.82
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
4,579,188
발행 주식
2,882,808
배당수익률
-
주가수익률
-0.92
주당순이익(EPS)
-17.28
매출
57k
순이익
-49.82M

Eyenovia Inc 정보

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precis... Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Eyenovia Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker EYEN. The last closing price for Eyenovia was US$15.82. Over the last year, Eyenovia shares have traded in a share price range of US$ 0.85 to US$ 124.80.

Eyenovia currently has 2,882,808 shares in issue. The market capitalisation of Eyenovia is US$45.61 million. Eyenovia has a price to earnings ratio (PE ratio) of -0.92.

EYEN 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10015.8215.8215.8200CS
410.565201.0466222655.25517.183.6850759368.63540113CS
1214.711325.225225231.1117.181.0245791885.25091923CS
2610.308187.0101596525.51217.180.8539561924.76953768CS
52-70.58-81.689814814886.4124.80.85800364910.99480709CS
156-125.94-88.8402934537141.764680.85300113325.25317035CS
260-197.78-92.5936329588213.6617.60.85192717248.29954088CS

EYEN - Frequently Asked Questions (FAQ)

What is the current Eyenovia share price?
The current share price of Eyenovia is US$ 15.82
How many Eyenovia shares are in issue?
Eyenovia has 2,882,808 shares in issue
What is the market cap of Eyenovia?
The market capitalisation of Eyenovia is USD 45.61M
What is the 1 year trading range for Eyenovia share price?
Eyenovia has traded in the range of US$ 0.85 to US$ 124.80 during the past year
What is the PE ratio of Eyenovia?
The price to earnings ratio of Eyenovia is -0.92
What is the cash to sales ratio of Eyenovia?
The cash to sales ratio of Eyenovia is 798.99
What is the reporting currency for Eyenovia?
Eyenovia reports financial results in USD
What is the latest annual turnover for Eyenovia?
The latest annual turnover of Eyenovia is USD 57k
What is the latest annual profit for Eyenovia?
The latest annual profit of Eyenovia is USD -49.82M
What is the registered address of Eyenovia?
The registered address for Eyenovia is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Eyenovia website address?
The website address for Eyenovia is www.eyenoviabio.com
Which industry sector does Eyenovia operate in?
Eyenovia operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
GTIGraphjet Technology
US$ 0.1459
(99.86%)
92.65M
NUWENewellis Inc
US$ 11.20
(62.44%)
1.27M
GAMEGameSquare Holdings Inc
US$ 2.08
(37.75%)
2.07M
DTSTData Storage Corporation
US$ 4.53
(34.02%)
586.7k
TNFATNF Pharmaceuticals Inc
US$ 0.1324
(24.67%)
6.05M
SLNHSoluna Holdings Inc
US$ 0.448
(-41.37%)
1.05M
CYCCCyclacel Pharmaceuticals Inc
US$ 7.76
(-37.06%)
66.98k
XELBXcel Brands Inc
US$ 1.16
(-28.40%)
228
PCLAPicoCELA Inc
US$ 0.6401
(-20.98%)
94.19k
GANXGain Therapeutics Inc
US$ 1.41
(-17.06%)
1.53k
GTIGraphjet Technology
US$ 0.1459
(99.86%)
92.65M
IXHLIncannex Healthcare Ltd
US$ 0.4227
(24.32%)
15.41M
TNFATNF Pharmaceuticals Inc
US$ 0.1324
(24.67%)
6.05M
NCNANuCana PLC
US$ 0.05
(-0.40%)
2.24M
GAMEGameSquare Holdings Inc
US$ 2.08
(37.75%)
2.07M

EYEN Discussion

게시물 보기
makinezmoney makinezmoney 2 주 전
$HYPD: $EYEN is now $HYPD


Now at $16 !!!!!!!!!!!

Wowwwwwwwwwwwwwww.......... good move


GO $HYPD
👍️0
makinezmoney makinezmoney 2 주 전
$HYPD: $EYEN is now $HYPD


Now at $16 !!!!!!!!!!!

Wowwwwwwwwwwwwwww.......... good move


GO $HYPD
👍️0
makinezmoney makinezmoney 2 주 전
$EYEN: Wooooooooooo weeeeeeeeeee.... now $16

She did it and she's doing it still.


GO $EYEN
👍️0
glenn1919 glenn1919 3 주 전
EYEN...............................................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 주 전
EYEN..............................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783#google_vignette
👍️0
makinezmoney makinezmoney 3 주 전
$EYEN: FInally cracking over $10 after that RS

Its been a long time coming.

Definitely getting some thrust action here


GO $EYEN
👍️0
glenn1919 glenn1919 3 주 전
EYEN................................p/m
👍️0
gail gail 1 월 전
huge run now. maybe merger happened?
👍️0
gail gail 1 월 전
rumor of merger news on…..

….

mon or tues, per stocktwits
👍️0
glenn1919 glenn1919 1 월 전
EYEN...........................................https://stockcharts.com/h-sc/ui?s=eyen&p=W&b=5&g=0&id=p86431144783
👍️0
crudeoil24 crudeoil24 1 월 전
June 2 > Form 424B5 - Prospectus [Rule 424(b)(5)]
👍️0
crudeoil24 crudeoil24 1 월 전
Trading float 2.75M shares
👍️0
crudeoil24 crudeoil24 1 월 전
Yearly revenues average $4,790. per employee.
👍️0
gail gail 1 월 전
blasting off! weeee!!!
👍️0
gail gail 1 월 전
yup, holding up great for a friday!
👍️0
Gator44 Gator44 1 월 전
she looks fixin to run
👍️0
gail gail 1 월 전
stocktwits said there may be a…

..

merger of some kind. dont know, dont care, but i like the past chart and how its moving post split.
👍️0
gail gail 1 월 전
it appears someone bought about……




$17mil worth (about 4mil shares) at about $4.40 pre market.
👍️0
gail gail 1 월 전
grabbed some on the dip. hi all.
👍️0
81vette 81vette 1 월 전
Green dragon 🐉 in my dreams
👍️ 2
glenn1919 glenn1919 1 월 전
EYEN....................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
81vette 81vette 1 월 전
Banging out the gate! Up 17% many catalysts inbound
👍️0
81vette 81vette 1 월 전
Looking fantastic again today,Inbound co. Value 44m,zero borrow not even flinching and 242% fee!! Golden atm,merger final will probably be delayed because it’s non- binding but I think a binding one will be enough for run up,this isn’t an in-house scam merger,I see it’s optionable now,looking at calls/puts,they plan on this becoming a huge company,pps is 70% above sma50 so loading has been going on awhile,lots of run room until sma200 makes this an attractive opportunity for investors,especially since the new fins!
👍️0
glenn1919 glenn1919 1 월 전
EYEN..................................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
shurtha2000 shurtha2000 1 월 전
Going to be a nice run up to Friday
👍️0
81vette 81vette 1 월 전
Lowest fill was 1.75
👍️0
81vette 81vette 1 월 전
Zero borrow this morning,they not loaning shares to short,I am buying bought 1.85(bids in for more if it drops)
👍️0
glenn1919 glenn1919 1 월 전
EYEN.................................................p/m
👍️0
Trev1966 Trev1966 2 월 전
Company News Out 5.30 pm Yesterday, Aftert Market Run As Well As Today, GLTA
👍️0
glenn1919 glenn1919 2 월 전
EYEN.....................................................................https://stockcharts.com/h-sc/ui?s=eyen&p=W&b=5&g=0&id=p86431144783




longtimenoc
👍️0
Monksdream Monksdream 3 월 전
EYEN under $2
👍️0
Monksdream Monksdream 3 월 전
EYEN, under $2
👍️0
Monksdream Monksdream 3 월 전
EYEN, new 52 week low
👍️0
Monksdream Monksdream 4 월 전
EYEN, new 52 week low
👍️0
Monksdream Monksdream 4 월 전
EYEN, new 52 week low
👍️0
Monksdream Monksdream 4 월 전
EYEN, new 52 week low
👍️0
Monksdream Monksdream 5 월 전
EYEN, new 52 week low

👍️0
Monksdream Monksdream 5 월 전
EYEN , new 52/week low


👍️0
georgie18 georgie18 6 월 전
EYEN...All out with a loss here...🥳

georgie18

Member Level
Re: georgie18 post# 70

Thursday, January 16, 2025 12:26:58 PM

Post#
74
of 74
EYEN...07...🥳...Averaging down on this dip...from my .12 Alert...

georgie18

Member Level
Re: None

Thursday, January 09, 2025 10:29:58 AM

Post#
670925
of 671550
EYEN...12...🥳... https://schrts.co/jpheeDNV ...Open Gap in the .30 range...
👍️0
georgie18 georgie18 6 월 전
EYEN...07...🥳...Averaging down on this dip...from my .12 Alert...

georgie18

Member Level
Re: None

Thursday, January 09, 2025 10:29:58 AM

Post#
670925
of 671550
EYEN...12...🥳... https://schrts.co/jpheeDNV ...Open Gap in the .30 range...
👍 1
tw0122 tw0122 6 월 전


👍️0
tw0122 tw0122 6 월 전
1/6  -- Eyenovia (EYEN) said Monday it is exploring strategic alternatives for its business and has hired Chardan as a financial adviser.
👍️0
tw0122 tw0122 6 월 전

..............,,,,On December 30, 2024, the Company entered into an Amended and Restated Sales Agreement (the “A&R Sales Agreement”) with Chardan Capital Markets, LLC (“Chardan”), as agent, which has been acknowledged and agreed by Leerink Partners LLC (“Leerink Partners”), with respect to the Company’s existing at-the-market offering program with an aggregate offering price of up to $50,000,000 of shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”). The A&R Sales Agreement amends and restates that certain Sales Agreement, dated December 14, 2021, by and between the Company and Leerink Partners (the “Initial Sales Agreement”) to, among other things, replace Leerink Partners with Chardan as sales agent. The Company sold an aggregate of $16,413,443 of shares of Common Stock under the Initial Sales Agreement. The Company will file a prospectus supplement relating to the offer and sale of the Common Stock pursuant to the A&R Sales Agreement, which will form a part of the Company’s Registration Statement on Form S-3 (File No. 333-282458), which was filed with the Securities and Exchange Commission on October 1, 2024 and declared effective on October 8, 2024. Subject to the terms and conditions of the A&R Sales Agreement, Chardan may sell shares of Common Stock by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415(a)(4) of the Securities Act of 1933, as amended (the “Securities Act”). Chardan will use commercially reasonable efforts to sell the Common Stock from time to time, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company will pay Chardan a commission equal to 3.0% of the gross sales proceeds of any Common Stock sold through Chardan under the A&R Sales Agreement. The Company is not obligated to make any sales of Common Stock under the A&R Sales Agreement. The offering of Common Stock will terminate upon the earlier of (i) the sale of all Common Stock subject to the A&R Sales Agreement or (ii) termination of the A&R Sales Agreement in accordance with its terms. The A&R Sales Agreement contains customary representations, warrantees and agreements between the Company and Chardan, including customary indemnification rights, including for liabilities under the Securities Act. The representations, warranties and covenants contained in the A&R Sales Agreement were made only for purposes of such agreement and as of specific dates and were solely for the benefit of the parties to such agreement. The foregoing description of the A&R Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the A&R Sales Agreement, a copy of which is filed as Exhibit 1.1 hereto and is incorporated herein by reference. The legal opinion of Covington & Burling LLP relating to the shares of Common Stock being offered is filed herewith as Exhibit 5.1. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the Common Stock nor shall there be any sale of the Common Stock in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Item 8.01. Other Events. Termination of Prior ATM Prospectus On December 29, 2024, prior to entry into the A&R Sales Agreement, the Company notified Leerink Partners that it was suspending and terminating the prospectus, dated October 8, 2024, relating to the sale of up to $25,000,000 of Common Stock, that could be issued and sold pursuant to the Initial Sales Agreement. Financial Update As of December 26, 2024, the Company had cash and cash equivalents of $2.2 million. Also as of December 26, 2024, the Company owed $10.1 million in principal and accrued interest under the Loan and Security Agreement, dated November 22, 2022, as amended, with Avenue Capital Management II, L.P., as administrative agent and collateral agent, Avenue Venture Opportunities Fund, L.P., as a lender and Avenue Venture Opportunities Fund II, L.P., as a lender. Item 9.01. Exhibits..... 
👍️0
georgie18 georgie18 6 월 전
EYEN...12...🥳... https://schrts.co/jpheeDNV ...Open Gap in the .30 range...
👍️0
glenn1919 glenn1919 6 월 전
EYEN..................................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 월 전
eyen....................................https://stockcharts.com/h-sc/ui?s=eyen&p=W&b=5&g=0&id=p86431144783




onit...............
👍️0
tw0122 tw0122 6 월 전
.30 + 150%
👍️0
tw0122 tw0122 6 월 전
8k keep an eye here 
👍️0
hondaboost hondaboost 8 월 전
Scam: selling 24 Million new shares at $0.10 , just before probable "Bankruptcy"!

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medication dispensing platform, today announced that it has entered into a securities purchase agreement with a healthcare focused institutional investor for the purchase and sale of 12,081,785 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 24,163,570 shares of common stock in a registered direct offering at a combined offering price of $0.1076 per share and accompanying warrants. T
👍️0
glenn1919 glenn1919 8 월 전
EYEN..............................https://stockcharts.com/h-sc/ui?s=EYEN&p=W&b=5&g=0&id=p86431144783
👍️0

최근 히스토리

Delayed Upgrade Clock